Emily Lelliott Eradicate Cancer 2018

Abstracts this author is presenting:

• A preclinical platform for evaluating targeted therapy and immunotherapy combinations in BRAF^V600E melanoma — SESSION X: Adoptive cellular immunotherapy (Part IV)